Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology.
暂无分享,去创建一个
[1] Michael Juhnke,et al. Accelerated Formulation Development for Nanomilled Active Pharmaceutical Ingredients Using a Screening Approach , 2010 .
[2] Marie-Isabelle Baraton,et al. Synthesis, Functionalization and Surface Treatment of Nanoparticles , 2002 .
[3] P. W. Carter,et al. Anion effects on electrostatic charging of sterically stabilized, water insoluble drug particles. , 2009, International journal of pharmaceutics.
[4] Yasuo Ida,et al. Solubilization behavior of a poorly soluble drug under combined use of surfactants and cosolvents. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[5] Koichi Wada,et al. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. , 2011, International journal of pharmaceutics.
[6] M. Mazzotti,et al. Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. , 2010, International journal of pharmaceutics.
[7] Huibi Xu,et al. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. , 2011, International journal of pharmaceutics.
[8] Patrick Augustijns,et al. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. , 2008, International journal of pharmaceutics.
[9] Elaine Merisko-Liversidge,et al. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. , 2011, Advanced drug delivery reviews.
[10] I. Ghosh,et al. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. , 2011, International journal of pharmaceutics.
[11] J-Y Choi,et al. Characteristics of polymers enabling nano-comminution of water-insoluble drugs. , 2008, International journal of pharmaceutics.
[12] M. K. Lee,et al. Hydrophilic and hydrophobic amino acid copolymers for nano-comminution of poorly soluble drugs. , 2010, International journal of pharmaceutics.
[13] Toshiyuki Niwa,et al. Universal wet-milling technique to prepare oral nanosuspension focused on discovery and preclinical animal studies - Development of particle design method. , 2011, International journal of pharmaceutics.
[14] R. Müller,et al. Nanosuspensions of poorly soluble drugs--reproducibility of small scale production. , 2000, International journal of pharmaceutics.
[15] P Amsa,et al. Nanosuspensions: A Promising Drug Delivery Strategy , 2010 .
[16] Brahmeshwar Mishra,et al. Lipid--an emerging platform for oral delivery of drugs with poor bioavailability. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[17] D. Burgess,et al. Scanning probe microscopy method for nanosuspension stabilizer selection. , 2009, Langmuir : the ACS journal of surfaces and colloids.
[18] E. Merisko-Liversidge,et al. Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds , 2008, Toxicologic pathology.
[19] Timo Laaksonen,et al. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. , 2011, International journal of pharmaceutics.
[20] Jonghwi Lee,et al. Role of polymeric stabilizers for drug nanocrystal dispersions , 2005 .
[21] S. Garg,et al. Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs. , 2010, Advanced drug delivery reviews.
[22] Ludo Froyen,et al. A screening study of surface stabilization during the production of drug nanocrystals. , 2009, Journal of pharmaceutical sciences.
[23] A Philip Plumb,et al. A decision-support tool for the formulation of orally active, poorly soluble compounds. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[24] I. Ghosh,et al. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[25] Rainer H Müller,et al. Nanocrystal technology, drug delivery and clinical applications , 2008, International journal of nanomedicine.
[26] K. Amighi,et al. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[27] S Kumar,et al. Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. , 2011, International journal of pharmaceutics.
[28] R. Müller,et al. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.
[29] Diane J Burgess,et al. Quality by design approach to understand the process of nanosuspension preparation. , 2009, International journal of pharmaceutics.
[30] K. Matsuzaki,et al. Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect. , 2010, International journal of pharmaceutics.
[31] Sanjay Garg,et al. Evaluation of a crystalline nanosuspension: polymorphism, process induced transformation and in vivo studies. , 2011, International journal of pharmaceutics.
[32] S. Stegemann,et al. When poor solubility becomes an issue: from early stage to proof of concept. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[33] Rainer H Müller,et al. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[34] Jian Zhang,et al. Physical and chemical stability of drug nanoparticles. , 2011, Advanced drug delivery reviews.
[35] Filippos Kesisoglou,et al. Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.
[36] Jouni Hirvonen,et al. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods , 2010, The Journal of pharmacy and pharmacology.
[37] C. Lipinski. Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.
[38] K. Amighi,et al. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. , 2005, International journal of pharmaceutics.
[39] Michael Lee Branham,et al. Preparation and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.